<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Are IOP Spikes Following Avastin Injections Related to Your Compounding Pharmacy?</title>
	<atom:link href="http://eyedocnews.com/002503-are-iop-spikes-following-avastin-injections-related-to-your-compounding-pharmacy/feed/" rel="self" type="application/rss+xml" />
	<link>http://eyedocnews.com/002503-are-iop-spikes-following-avastin-injections-related-to-your-compounding-pharmacy/</link>
	<description>Ophthalmology on the Web</description>
	<lastBuildDate>Mon, 21 May 2012 18:33:03 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
	<item>
		<title>By: Irv Arons</title>
		<link>http://eyedocnews.com/002503-are-iop-spikes-following-avastin-injections-related-to-your-compounding-pharmacy/comment-page-1/#comment-887</link>
		<dc:creator>Irv Arons</dc:creator>
		<pubDate>Wed, 11 Nov 2009 03:39:37 +0000</pubDate>
		<guid isPermaLink="false">http://eyedocnews.com/?p=2503#comment-887</guid>
		<description>OK, I received copies of the email blast that the Academy sent out to its members during the meeting and in one was a more detailed excerpt of Dr. Kahook&#039;s talk, which turned out to be at the Glaucoma SubSpecialty Day session, not at the Retina Session, as I thought.

In any event, I have added the additional details to my original writeup.

Anyone interested can click on the URL link in my posting above and see the new details.

Irv</description>
		<content:encoded><![CDATA[<p>OK, I received copies of the email blast that the Academy sent out to its members during the meeting and in one was a more detailed excerpt of Dr. Kahook&#8217;s talk, which turned out to be at the Glaucoma SubSpecialty Day session, not at the Retina Session, as I thought.</p>
<p>In any event, I have added the additional details to my original writeup.</p>
<p>Anyone interested can click on the URL link in my posting above and see the new details.</p>
<p>Irv</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Randall V. Wong, M.D.</title>
		<link>http://eyedocnews.com/002503-are-iop-spikes-following-avastin-injections-related-to-your-compounding-pharmacy/comment-page-1/#comment-789</link>
		<dc:creator>Randall V. Wong, M.D.</dc:creator>
		<pubDate>Mon, 02 Nov 2009 21:56:22 +0000</pubDate>
		<guid isPermaLink="false">http://eyedocnews.com/?p=2503#comment-789</guid>
		<description>I, too, have had a few questions.  I called my compounding pharmacy, they don&#039;t understand the issue.

From their perspective, this is a sterile-to-sterile transfer.  They take an aliquot from a larger vial (supplied by Genetech) and place into a smaller vial under sterile conditions.  

Randy</description>
		<content:encoded><![CDATA[<p>I, too, have had a few questions.  I called my compounding pharmacy, they don&#8217;t understand the issue.</p>
<p>From their perspective, this is a sterile-to-sterile transfer.  They take an aliquot from a larger vial (supplied by Genetech) and place into a smaller vial under sterile conditions.  </p>
<p>Randy</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Irv Arons</title>
		<link>http://eyedocnews.com/002503-are-iop-spikes-following-avastin-injections-related-to-your-compounding-pharmacy/comment-page-1/#comment-788</link>
		<dc:creator>Irv Arons</dc:creator>
		<pubDate>Mon, 02 Nov 2009 21:49:00 +0000</pubDate>
		<guid isPermaLink="false">http://eyedocnews.com/?p=2503#comment-788</guid>
		<description>Randall,

I also wrote this up for my online Journal (link: http://tinyurl.com/AvastinUpdate31) and tried to get Dr. Kahook to answer several additional questions, such as:

What are the other states that have reported problems?
Is their a reference site to look at?
Who is doing the investigation -- FDA, NIH, or Genentech?

But he refused to answer -- saying I would have to wait for his publication to get these answers.

Also, he appears to be a paid consultant for Genentech -- so that should be borne in mind in his presentation.

Irv</description>
		<content:encoded><![CDATA[<p>Randall,</p>
<p>I also wrote this up for my online Journal (link: <a href="http://tinyurl.com/AvastinUpdate31" rel="nofollow">http://tinyurl.com/AvastinUpdate31</a>) and tried to get Dr. Kahook to answer several additional questions, such as:</p>
<p>What are the other states that have reported problems?<br />
Is their a reference site to look at?<br />
Who is doing the investigation &#8212; FDA, NIH, or Genentech?</p>
<p>But he refused to answer &#8212; saying I would have to wait for his publication to get these answers.</p>
<p>Also, he appears to be a paid consultant for Genentech &#8212; so that should be borne in mind in his presentation.</p>
<p>Irv</p>
]]></content:encoded>
	</item>
</channel>
</rss>

